{"prompt": "['NRG ONCOLOGY', 'NRG-GU003', 'A RANDOMIZED PHASE III TRIAL OF HYPOFRACTIONATED POST-', 'PROSTATECTOMY RADIATION THERAPY (HYPORT) VERSUS CONVENTIONAL', 'POST-PROSTATECTOMY RADIATION THERAPY (COPORT)', 'CONTACT INFORMATION(26-APR-2019)', 'For regulatory requirements:', 'For patient enrollments:', 'For study data submission:', 'Regulatory documentation must', 'Please refer to the patient', 'Data collection for this study', 'be submitted to the CTSU via', 'enrollment section of the protocol', 'will be done exclusively through', 'the Regulatory Submission', 'for instructions on using the', 'Medidata Rave. Please see the', 'Portal. : (Sign in at', 'Oncology Patient Enrollment', 'data submission section of the', 'www.ctsu.org, and select the', 'Network (OPEN) which can be', 'protocol for further instructions.', 'Regulatory Submission sub-', 'accessed at', 'tab under the Regulatory', 'https://www.ctsu.org/OPEN: SYS', 'tab.)', 'TEM/ or https://OPEN.ctsu.org.', 'Institutions with patients', 'Contact the CTSU Help Desk', 'waiting that are unable to use', 'with any OPEN-related questions', 'the Portal should alert the', 'at ctsucontact@westat.com.', 'CTSU Regulatory Office', 'immediately at 1-866-651-2878', 'to receive further instruction', 'and support.', 'Contact the CTSU Regulatory', 'Help Desk at 1-866-651-2878', 'for regulatory assistance.', 'The most current version of the study protocol and all supporting documents must be downloaded', 'from the protocol-specific Web page of the CTSU Member Web site located at https://www.ctsu.org.', \"Access to the CTSU members' website is managed through the Cancer Therapy and Evaluation Program\", '- Identity and Access Management (CTEP-IAM) registration system and requires user log on with', 'CTEP-IAM username and password.', 'For clinical questions, contact the Study PI of the Lead Protocol Organization.', 'For questions concerning eligibility, please contact the Biostatistical/Data Management Center (via the', 'contact list on the protocol cover page). For radiation therapy-related eligibility questions, please contact', 'RTQA (via the contact list on the protocol cover page).', 'For non-clinical questions (i.e. unrelated to patient eligibility, treatment, or clinical data', 'submission) contact the CTSU Help Desk by phone or e-mail:', 'CTSU General Information Line - 1-888-823-5923, or ctsucontact@@westat.com. All calls and', 'correspondence will be triaged to the appropriate CTSU representative.', 'The CTSU Website is located at https://www.ctsu.org.', 'NRG-GU003', '6', 'Version Date: April 26, 2019']['TABLE OF CONTENTS', 'NRG-GU003', '9', 'SCHEMA', '9', '1. OBJECTIVES', '10', '1.1', 'Primary Objective', '10', '1.2', 'Secondary Objectives', '10', '1.3', 'Exploratory Objectives', '10', '2. BACKGROUND', '10', '2.1', 'Prostate Cancer is the Second Most Common Cancer in Men', '10', '2.2', 'Rationale for Hypofractionation', '11', '2.3', 'This trial is important because:', '15', '3. PATIENT SELECTION, ELIGIBILITY, AND INELIGIBILTY CRITERIA', '15', '3.1', 'Patient Selection Guidelines', '15', '3.2', 'Eligibility Criteria', '16', '3.3', 'Ineligibility Criteria', '17', '4. REQUIREMENTS FOR STUDY ENTRY, TREATMENT, AND FOLLOW-UP', '18', '5. TREATMENT PLAN/REGIMEN DESCRIPTION', '20', '5.1', 'Chemotherapy/Hormonal Therapy/Other Agent-Based Therapy', '20', '5.2', 'Radiation Therapy', '20', '5.3', 'General Concomitant Medication and Supportive Care Guidelines', '27', '5.4', 'Duration of Therapy', '27', '6. TREATMENT MODIFICATIONS/MANAGEMENT.', '27', '7.', 'ADVERSE EVENTS REPORTING REQUIREMENTS', '28', '7.1', 'Protocol Agents', '28', '7.2', 'Adverse Events and Serious Adverse Events', '28', '7.3', 'Expedited Reporting of Adverse Events', '28', '8.', 'REGISTRATION, STUDY ENTRY, AND WITHDRAWAL PROCEDURES', '32', '8.1', 'Investigator Registration Requirements', 'Error! Bookmark not defined.', '8.2', 'RT-Specific Pre-Registration Requirements', '34', '8.3', 'Patient Enrollment', '36', '9.0', 'DRUG INFORMATION', '37', '9.1', 'Commercial Agents.', '37', '10.', 'PATHOLOGY/BIOSPECIMEN', '37', '10.1', 'Biospecimen Submission Tables', '37', 'NRG-GU003', '7', 'Version Date: April 26, 2019']\n\n###\n\n", "completion": "END"}